Evidence map›Paper›PMID 29703167›Full record

ArticleBMC cancer2018

Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.

Hongyun Wang, Xiaodong Cheng, Jing Ye, Xiuyun Xu, Ying Hong, Long Sui, Zhixue You, Xing Xie

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Association BetweenFrontiers in genetics · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. HPV infection patterns and viral load distribution: implication on cervical cancer prevention in Western Kenya.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hongyun WangDepartment of Gynecological Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
Xiaodong ChengDepartment of Gynecological Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
Jing YeDepartment of Gynecological Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
Xiuyun XuNanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Ying HongNanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Long SuiObstetrics and Gynecology Hospital of Fudan University, Fudan, China.
Zhixue YouThe First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xing XieDepartment of Gynecological Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China. xiex@zju.edu.cn.
Nanjing Drum Tower Hospital · CNWomen's Hospital, School of Medicine, Zhejiang University · CNJiangsu Province Hospital · CNObstetrics and Gynecology Hospital of Fudan University · CN

Funding

Science and Technology Department of Jiangsu province science and technology support programme - social development issues (CHINA) BE2012606
6 · The paper itself

Abstract

backgroundThis study aimed to provide more information for cancer prevention strategies by determining the distribution of human papilloma virus (HPV) genotype prevalence in invasive cervical carcinoma (ICC) and precancerous lesion patients in the Yangtze River Delta area in China.

methodsThis multi-centre descriptive cross-sectional study involves four university hospitals in the Jiangzhehu area. Women with histologically confirmed cervical intraepithelial neoplasia (CIN) 1, CIN2, CIN3 or ICC who were diagnosed and treated in the four selected hospitals between February 2012 and April 2014 were eligible for recruitment. The average age of the patients was 40.93 ± 11.87 years old, among whom the youngest was 17 years old and the oldest was 76 years old.Those with immunodeficiency diseases or a previous history of cancer or CIN were excluded. HPV genotyping was performed by a central laboratory. The distribution and age and disease specificity of the HPV genotype prevalence were analysed.

resultsOf the 2181 collected samples, 251 were ICC and 1930 were CIN. The mean age of cervical cancer and CIN patients was 40.93 ± 11.8 years (range, 17-76 years). The five most commonly identified HPV types in each lesion class were as follows: CIN1: 52, 58, 16, 33, and CP; CIN2: 16, 58, 52, 33, and 31; CIN3: 16, 58, 33, 52, and 31; and ICC: 16, 58, 18, 52, and 33. CIN1 had an earlier age of onset (30-40 years) than CIN2, CIN3, and cervical cancer. The age of onset of cervical cancer exhibited two peaks at 40-44 and 50-54 years of age. In all infected patients, the frequency of HPV infection with a single type was 62.9%, and with multiple types, it was 38.1%. There was no difference in the frequencies of multiple types amongst the different cervical lesions.

conclusionsThe most prevalent genotypes in the investigated area (52, 58, 16 and 18) justify the necessity of anti-HPV vaccination in teenagers and young girls under 24 years old in the Yangtze River Delta area in China. Infection with multiple high-risk HPV types versus single infection does not increase the risk for ≥ CIN2 in ICC development.

Indexed as

GenotypePrecancerous ConditionsAdolescentAdultAgedAlphapapillomavirusChinaFemaleHumansMiddle AgedNeoplasm StagingPapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsYoung AdultCervical intraepithelial neoplasia (CIN)Human papilloma virus (HPV)Invasive cervical cancer (ICC)

Identifiers

PMID29703167
PMCPMC5924433
OpenAlexW2807097048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.